Insider Selling: Privia Health Group (NASDAQ:PRVA) CEO Sells 27,229 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 27,229 shares of the firm’s stock in a transaction on Friday, March 13th. The shares were sold at an average price of $21.52, for a total value of $585,968.08. Following the completion of the sale, the chief executive officer owned 581,952 shares in the company, valued at approximately $12,523,607.04. This represents a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Parth Mehrotra also recently made the following trade(s):

• On Thursday, March 12th, Parth Mehrotra sold 26,763 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total value of $586,109.70.
• On Tuesday, March 10th, Parth Mehrotra sold 21,097 shares of Privia Health Group stock. The shares were sold at an average price of $22.71, for a total value of $479,112.87.
• On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The stock was sold at an average price of $22.86, for a total value of $960,097.14.
• On Friday, March 6th, Parth Mehrotra sold 21,440 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total value of $496,336.00.

Privia Health Group Stock Up 1.3%

PRVA traded up $0.28 on Monday, reaching $21.96. The company’s stock had a trading volume of 633,287 shares, compared to its average volume of 805,784. The stock has a 50 day moving average of $22.89 and a two-hundred day moving average of $23.61. The company has a market capitalization of $2.72 billion, a price-to-earnings ratio of 129.18, a P/E/G ratio of 1.37 and a beta of 0.82. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21. The company had revenue of $541.17 million for the quarter, compared to analysts’ expectations of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The firm’s revenue for the quarter was up 17.4% on a year-over-year basis. During the same quarter last year, the company earned $0.21 earnings per share. As a group, analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Stephens reissued an “overweight” rating and issued a $32.00 price target on shares of Privia Health Group in a research report on Thursday, December 4th. Jefferies Financial Group reiterated a “buy” rating and set a $32.00 target price on shares of Privia Health Group in a research report on Thursday, February 26th. Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a report on Monday, December 29th. Citigroup decreased their target price on Privia Health Group from $34.00 to $32.00 and set a “buy” rating for the company in a research report on Tuesday, March 3rd. Finally, Wolfe Research set a $31.00 price target on Privia Health Group in a research note on Tuesday, January 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Privia Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.00.

Institutional Trading of Privia Health Group

A number of large investors have recently bought and sold shares of the business. Royal Bank of Canada increased its stake in Privia Health Group by 63.5% in the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock valued at $5,514,000 after purchasing an additional 95,371 shares during the period. AQR Capital Management LLC boosted its stake in shares of Privia Health Group by 24.7% during the first quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock worth $916,000 after buying an additional 8,068 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Privia Health Group by 3.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company’s stock worth $2,666,000 after buying an additional 3,714 shares during the last quarter. Intech Investment Management LLC increased its position in Privia Health Group by 55.1% in the 1st quarter. Intech Investment Management LLC now owns 56,553 shares of the company’s stock valued at $1,270,000 after acquiring an additional 20,082 shares during the period. Finally, Acadian Asset Management LLC purchased a new stake in Privia Health Group during the 1st quarter valued at approximately $154,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.